8 matches for your search in the start-up spotlight
rss
HAYA Therapeutics is a precision medicines company developing programmable therapeutics targeting regulatory RNAs derived from the dark genome, a cell information processing unit, to reprogram pathological cell states for a broad range of diseases, including cardiovascular disease and cancer. The ...
Limula provides an innovative solution for the production of the most personalised cancer treatments on demand and at scale. Our product is a unique proprietary platform can perform multiple steps of cell therapy manufacturing in a single device, using end-to-end automation and integrated process ...
Based in Lausanne, Switzerland, NewBiologix SA is a technology innovation company developing a proprietary and breakthrough DNA integration platform for the advanced engineering of human and mammalian cell lines. NewBiologix is committed to improve the generation and production of viral vectors ...
Founded in Switzerland in 2021 by Tommi Lehtonen, Damien Lapray and Christian Meisel, Hedera Dx is on a mission to make liquid biopsies a reality in clinical practice globally, in order to help more cancer patients get better therapy options and better outcomes. The Hedera Dx liquid biopsy ...
Parithera enables accurate treatment decision guidance & monitoring from one simple blood draw An alternative to tissue biopsy is to study cells which detach from the solid tumors and find access to the blood stream. The so-called circulating tumor cells (CTCs) are retrieved via Liquid ...
We are a swiss AI startup doing medical image diagnosis with AI. Our mission to aid doctors to be efficient and accurate at diagnosis. We are computer scientists and biologists who understand medical images and AI to customize diagnosis for each specific problem
